AACR Annual Meeting 2011 Day 2 Highlights from Pharma Strategy Blog
Description: Sally Church, PhD from Pharma Strategy Blog records her highlights from Sunday, April 3rd 2011, Day 2 of the 102nd American Association for Cancer Research (AACR) annual meeting in Orlando. Sally discusses the plenary presentation by Dr Harold Varmus of the National Cancer Institute (NCI), the questions he posed to the audience and the need for all involved with cancer to write to their Senators and Representatives to support the NCI as it faces budget cuts. She reviews the phase II data presented in the plenary session by Dr Ervin Epstein for GDC-0449 , a hedgehog pathway inhibitor, for the prevention of basal cell carcinoma in basal cell nevus syndrome (BCNS) patients. The other highlight of day 2 that Sally discusses is the launch of a new journal by AACR, "Cancer Discovery."
Shared By : feeds
Posted on : 05/18/11
Added : 7 years ago